Keyphrases
Anti-AIDS Drugs
100%
Hepatic Metabolism
100%
Oral Bioavailability
100%
Drug Bioavailability
50%
Oral Drug Bioavailability
50%
Drug Permeation
50%
Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)
50%
Opportunistic Infections
50%
Intestinal Transport
50%
Antiherpetic
50%
Mechanism-based
50%
Molecular Mechanism
50%
Specific Intent
50%
Intestine
50%
Carrier-mediated
50%
Epithelial Barrier
50%
Low-to-moderate
50%
Saquinavir
50%
Ritonavir
50%
Oral Drug Absorption
50%
Regional Dependence
50%
Transport Parameters
50%
Gastrointestinal
50%
Valacyclovir
50%
Metabolism Parameters
50%
New Drugs
50%
HIV Protease Inhibitors
50%
Cellular Mechanisms
50%
Hepatic Transport
50%
Secretory Transport
50%
Transport Mechanism
50%
Drug Interactions
50%
Intestinal Metabolism
50%
Intestinal mucosa
50%
AIDS-related Opportunistic Infections
50%
Pharmacokinetics
50%
Clinically Significant
50%
AIDS Patients
50%
Pharmacology, Toxicology and Pharmaceutical Science
Bioavailability
100%
Opportunistic Infection
40%
Valaciclovir
20%
Ritonavir Plus Saquinavir
20%
Delavirdine
20%
Lobucavir
20%
Human Immunodeficiency Virus Proteinase Inhibitor
20%
Drug Absorption
20%
Nonnucleoside Reverse Transcriptase Inhibitor
20%
Drug Interaction
20%
Pharmacokinetics
20%